Archives

by in
Entry Author Date Location
Vertex’s Matt Emmens on His Journey From Security Guard to CEO 01/27/10 Boston
Gilead Deepens Roots in Seattle, Seeks Long-Term Payoff From Lung Disease Research 01/13/10 Seattle
Gilead Cystic Fibrosis Drug Gets Green Light From FDA Panel 12/10/09 Seattle
Vertex Snags Extra $58M 12/04/09 Boston
Vertex Raises $443M in Yet Another Monster Stock Sale 12/03/09 Boston
Domain Raises a $500M VC Fund, Dissident Prods Amylin Again, Avanir Passes Pivotal Test, & More San Diego Life Sciences News 08/13/09 San Diego
Vertex Drug Could Be “Man on the Moon” for Cystic Fibrosis Therapy, Says Researcher Bonnie Ramsey 08/07/09 National
Cash Running Low at Altus Pharma 08/05/09 Boston
Pulmatrix, With One Drug for Multiple Bugs, Aims to Fundamentally Change Flu Treatment 06/09/09 Boston
Alnara Pharma Completes Key Cystic Fibrosis Drug Trial, “Extremely Encouraged” by Results 05/28/09 Boston
Vertex Starts Pivotal CF Trials 05/27/09 Boston
Obama Stimulates UW, Public Biotechs Run Low on Cash, Healionics Ships Glaucoma Product & More Seattle-Area Life Sciences News 03/26/09 Seattle
Sticking to its Guns with Gene Therapy, Genzyme To Present Key Findings Within Days 03/25/09 Boston
Alnara Leapfrogs Into Phase III, Just Six Months After Getting Started 03/25/09 Boston
EU Spurns Gilead’s Aztreonam 03/20/09 Seattle
Epix Reaches Milestone in CF Research 03/11/09 Boston
Early Histogen Study Offers Hope for Retreating Hairlines, Cadence Pharmaceuticals and Vertex Raise Lots of Cash, Unmanned Predator Begins New Air Patrol, & More San Diego BizTech News 02/23/09 San Diego
Out With Hedge Funds, In With Blue Bloods: Vertex Transforms Investor Base Via Stock Sale 02/20/09 Boston
Vertex Raises $320M in Secondary Stock Offering 02/19/09 Boston
Mpex Pharma Lands $27.5M in Fourth Round 02/10/09 San Diego
Vertex CEO Josh Boger Retiring In May; Matthew Emmens To Fill Role 02/05/09 Boston
Altus Cuts 75 Percent of Staff 01/26/09 Boston
KaloBios Gets $12M Genzyme, Baxter 12/22/08 Boston
Luck, Curiosity, Naivete: The Essential Ingredients of Innovation 12/16/08 Seattle
Economy Makes Disease Foundations Get Choosier 12/15/08 Boston
Sequenom May Spot Single-Gene Birth Defects, like Cystic Fibrosis, in a Sample of Mother’s Blood 11/24/08 San Diego
Simple DNA Test Spots Deadly MRSA Bacteria; Adnavance Aims To Take It Mainstream 11/10/08 San Diego
Vertex Cystic Fibrosis Drug Improves Breathing for 28 Days 10/20/08 Boston
Pulmatrix, Emerging From Stealth Mode, Makes Aerosols to Kill Flu and Bacterial Bugs in the Lungs 09/18/08 Boston
Gilead Drug For Cystic Fibrosis Fails to Win FDA Approval 09/16/08 Seattle
Page 3 of 4 « previous page · next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  5. Do You Need an Extended Warranty? Do the Math, Says SquareTrade

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.